Baltimore investment firm founded by Matthew Hellauer, focused on healthcare, life sciences and technology that improves care. Its investments include AI infrastructure for clinical development, simulation for medical devices and technology-enabled care delivery. Public sources identify investment professionals and physician collaborators, with some team titles undisclosed.